Looking ahead, the development of ultra-long-acting insulins like insulin icodec, which could offer once-weekly injections, along with combinations such as insulin icodec with semaglutide, offers exciting possibilities for simplifying diabetes care even further. The gene discussed is INS; the disease is diabetes mellitus.